189 results on '"Kishida, Satoshi"'
Search Results
2. The Involvement of Midkine, a Heparin-Binding Growth Factor, in Cancer Development
3. The list of PRC2 target genes and the result of microarray analysis from PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma
4. Supplementary Materials and Methods from PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma
5. An array CGH of TH-MYCN spheres and tumor tissues from PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma
6. Supplementary Figures from PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma
7. A microarray analysis of RA (+) and (-) spheres from PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma
8. Data from PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma
9. Data from The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma
10. Supplementary Methods, Tables 1-2, Figures 1-4 from The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma
11. Data from Midkine Promotes Neuroblastoma through Notch2 Signaling
12. Supplementary Methods, Figure Legend, Table 1, Figures 1-8 from Midkine Promotes Neuroblastoma through Notch2 Signaling
13. Neuroblastoma Patients: Plasma Growth Factor Midkine as a Prognostic Growth Factor
14. Cyclopropenes for the Stepwise Synthesis of 1,2,4,5-Tetraarylbenzenes via 1,4-Cyclohexadienes
15. Establishment of a new conditionally immortalized cell line from human brain microvascular endothelial cells: A promising tool for human blood–brain barrier studies
16. Influence of coating method on catalyst activity of AgCl/Al 2O 3/SUS304 composite plate
17. Effect of manufacturing methods of AgCl/Al 2O 3 catalyst on selective catalytic reduction of NO x
18. NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK
19. Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation
20. Coating of γ-Al 2O 3 on the stainless steel substrate by electrophoretic deposition method
21. Transforming growth factor-β1 upregulates keratan sulfate and chondroitin sulfate biosynthesis in microglias after brain injury
22. Therapeutic potential of midkine in cardiovascular disease
23. The Involvement of Midkine, a Heparin-Binding Growth Factor, in Cancer Development
24. Involvement of ASK1 in Ca2+‐induced p38 MAP kinase activation
25. The heparin-binding growth factor midkine: the biological activities and candidate receptors
26. Neuroblastoma Patients: Plasma Growth Factor Midkine as a Prognostic Growth Factor
27. CD48 as a novel molecular target for antibody therapy in multiple myeloma
28. Study on Coating Method to the Stainless Steel Substrate Top of Ag/Al2O3 Catalyst System
29. Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in MYCN ‐amplified neuroblastoma cells
30. Plasma midkine level is a prognostic factor for human neuroblastoma
31. TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway
32. TAB2, a Novel Adaptor Protein, Mediates Activation of TAK1 MAPKKK by Linking TAK1 to TRAF6 in the IL-1 Signal Transduction Pathway
33. Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes
34. PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma
35. Temporally and Spatially Regulated Expression of the Linker Histone H1fx During Mouse Development
36. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAKI, HIPK2, and NLK
37. De l'autre / à l'autre, Merleau-Ponty et l'autre
38. L'interview comme expérience de la proximité : L'interview et L'evinas
39. Functional Analysis of Purine Nucleoside Phosphorylase as a Key Enzyme in Ribavirin Metabolism
40. Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease
41. Nucleolar protein PES 1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation
42. IL-1シグナル伝達経路におけるアダプター/スカフォールドタンパク質TAB2の作用機構
43. Hydrocortisone enhances the barrier properties of HBMEC/ciβ, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects
44. DRR1 is expressed in the developing nervous system and downregulated during neuroblastoma carcinogenesis
45. Inactivation of SMC2 shows a synergistic lethal response inMYCN-amplified neuroblastoma cells
46. Plasma Midkine Level Is a Prognostic Factor for Human Neuroblastoma
47. A New Tumorsphere Culture Condition Restores Potentials of Self-Renewal and Metastasis of Primary Neuroblastoma in a Mouse Neuroblastoma Model
48. ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma
49. Midkine Promotes Neuroblastoma through Notch2 Signaling
50. Abstract 2963: ALK is a MYCN target gene and contributes to cell growth, migration and invasion in neuroblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.